chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: warmth; itchy at injection site; swollen; redness; injection site rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warmth), VACCINATION SITE PRURITUS (itchy at injection site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (redness) and INJECTION SITE RASH (injection site rash) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMITRIPTYLINE, BUPROPION, ATENOLOL, EMPAGLIFLOZIN (JARDIANCE), ATORVASTATIN, SEMAGLUTIDE (OZEMPIC), METFORMIN and TRAZODONE for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (warmth), VACCINATION SITE PRURITUS (itchy at injection site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (redness) and INJECTION SITE RASH (injection site rash). The patient was treated with PREDNISONE for Rash, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE WARMTH (warmth), VACCINATION SITE PRURITUS (itchy at injection site), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown and INJECTION SITE RASH (injection site rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided    Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Added a new event Rash and its treatment medication.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Epistaxis, Headache, Mouth swelling, Skin discolouration
Clinical narrative: Swelling of her tongue; Swelling of her mouth; Chest felt tight; Nosebleed, intermittent; Intermittent headaches; Her crotch became swollen/swollen; Her crotch was of a magenta red color / the area of her crotch has faded in color but has not returned to skin tone color; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EPISTAXIS (Nosebleed, intermittent), SWELLING (Her crotch became swollen/swollen), SWOLLEN TONGUE (Swelling of her tongue), MOUTH SWELLING (Swelling of her mouth) and CHEST DISCOMFORT (Chest felt tight) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Tequin gave her a heart attack) and Diabetes mellitus.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced SWELLING (Her crotch became swollen/swollen) and SKIN DISCOLOURATION (Her crotch was of a magenta red color / the area of her crotch has faded in color but has not returned to skin tone color). On 25-Apr-2021, the patient experienced EPISTAXIS (Nosebleed, intermittent) and HEADACHE (Intermittent headaches). On 01-May-2021, the patient experienced SWOLLEN TONGUE (Swelling of her tongue), MOUTH SWELLING (Swelling of her mouth) and CHEST DISCOMFORT (Chest felt tight). At the time of the report, EPISTAXIS (Nosebleed, intermittent) and HEADACHE (Intermittent headaches) had not resolved, SWELLING (Her crotch became swollen/swollen), SWOLLEN TONGUE (Swelling of her tongue), MOUTH SWELLING (Swelling of her mouth) and CHEST DISCOMFORT (Chest felt tight) outcome was unknown and SKIN DISCOLOURATION (Her crotch was of a magenta red color / the area of her crotch has faded in color but has not returned to skin tone color) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provider by the reporter.  No treatment medications were taken.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Swollen tongue
Clinical narrative: Swelling of her tongue; Swelling of her mouth; Chest felt tight; Nosebleed, intermittent; Intermittent headaches; Her crotch became swollen/swollen; Her crotch was of a magenta red color / the area of her crotch has faded in color but has not returned to skin tone color; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EPISTAXIS (Nosebleed, intermittent), SWELLING (Her crotch became swollen/swollen), SWOLLEN TONGUE (Swelling of her tongue), MOUTH SWELLING (Swelling of her mouth) and CHEST DISCOMFORT (Chest felt tight) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Tequin gave her a heart attack) and Diabetes mellitus.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced SWELLING (Her crotch became swollen/swollen) and SKIN DISCOLOURATION (Her crotch was of a magenta red color / the area of her crotch has faded in color but has not returned to skin tone color). On 25-Apr-2021, the patient experienced EPISTAXIS (Nosebleed, intermittent) and HEADACHE (Intermittent headaches). On 01-May-2021, the patient experienced SWOLLEN TONGUE (Swelling of her tongue), MOUTH SWELLING (Swelling of her mouth) and CHEST DISCOMFORT (Chest felt tight). At the time of the report, EPISTAXIS (Nosebleed, intermittent) and HEADACHE (Intermittent headaches) had not resolved, SWELLING (Her crotch became swollen/swollen), SWOLLEN TONGUE (Swelling of her tongue), MOUTH SWELLING (Swelling of her mouth) and CHEST DISCOMFORT (Chest felt tight) outcome was unknown and SKIN DISCOLOURATION (Her crotch was of a magenta red color / the area of her crotch has faded in color but has not returned to skin tone color) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provider by the reporter.  No treatment medications were taken.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: A dose was withdrawn and given to patient from the vial which was out for more than > 12 hrs; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A dose was withdrawn and given to patient from the vial which was out for more than > 12 hrs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A dose was withdrawn and given to patient from the vial which was out for more than > 12 hrs). On 07-May-2021, EXPIRED PRODUCT ADMINISTERED (A dose was withdrawn and given to patient from the vial which was out for more than > 12 hrs) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Heart rate increased, Hypotension, Pyrexia
Clinical narrative: Blood pressure low 88/49; heart rate over 100 beats per minute; fever 103 F; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-May-2021 and was forwarded to Moderna on 07-May-2021.    This spontaneous case was reported by a patient and describes the occurrence of HYPOTENSION (Blood pressure low 88/49), HEART RATE INCREASED (heart rate over 100 beats per minute) and PYREXIA (fever 103 F) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol, Hypertension, GERD and Pain. Concomitant products included VALSARTAN for Blood pressure high, OMEPRAZOLE for GERD, SIMVASTATIN for Hyperlipidemia, MELOXICAM for Pain.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced HYPOTENSION (Blood pressure low 88/49), HEART RATE INCREASED (heart rate over 100 beats per minute) and PYREXIA (fever 103 F). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 02-Apr-2021, HYPOTENSION (Blood pressure low 88/49), HEART RATE INCREASED (heart rate over 100 beats per minute) and PYREXIA (fever 103 F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Blood pressure measurement: abnormal (Low) BP: 88/49. On 02-Apr-2021, Body temperature: abnormal (High) 103F.         This case was linked to MOD-2021-114539 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Jul-2021: follow up received on 4-jul-2021 no new information was received
Sex: M
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Unspecific Adverse Event; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Unspecific Adverse Event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Unspecific Adverse Event). At the time of the report, ADVERSE EVENT (Unspecific Adverse Event) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain, Pyrexia
Clinical narrative: swollen below the injection site (in the same arm; red below the injection site; hurts a lot below the injection site; pain; quite a fever (yesterday she still had); This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (quite a fever (yesterday she still had)), INJECTION SITE SWELLING (swollen below the injection site (in the same arm), INJECTION SITE ERYTHEMA (red below the injection site), INJECTION SITE PAIN (hurts a lot below the injection site) and PAIN (pain) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 004C21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, High cholesterol, Blood pressure high and Asthma. Concomitant products included SITAGLIPTIN PHOSPHATE (JANUVIA) for Diabetic.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced PYREXIA (quite a fever (yesterday she still had)). On 06-May-2021, the patient experienced INJECTION SITE SWELLING (swollen below the injection site (in the same arm), INJECTION SITE ERYTHEMA (red below the injection site), INJECTION SITE PAIN (hurts a lot below the injection site) and PAIN (pain). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, PYREXIA (quite a fever (yesterday she still had)), INJECTION SITE SWELLING (swollen below the injection site (in the same arm), INJECTION SITE ERYTHEMA (red below the injection site), INJECTION SITE PAIN (hurts a lot below the injection site) and PAIN (pain) outcome was unknown. Not Provided          Patient also takes medicine for her high cholesterol, high blood pressure, and asthma.   This case was linked to MOD21-088035, US-MODERNATX, INC.-MOD-2021-114643 (Linked Report).; Sender's Comments:  MOD21-088035:Daughter's case US-MODERNATX, INC.-MOD-2021-114643:Mother case
Age: 50.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Arthralgia, Chest pain, Fatigue, Pain, Pain in extremity
Clinical narrative: sudden and quick pain in my chest; pain in her arm; Joint pain; Tiredness; pain comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (sudden and quick pain in my chest), PAIN IN EXTREMITY (pain in her arm), ARTHRALGIA (Joint pain), FATIGUE (Tiredness) and PAIN (pain comes and goes) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.    Co-suspect product included non-company product IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.    No medical history was provided by the reporter.  The patient's past medical history included No adverse reaction. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started IBUPROFEN (ADVIL [IBUPROFEN]) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (sudden and quick pain in my chest), PAIN IN EXTREMITY (pain in her arm), ARTHRALGIA (Joint pain), FATIGUE (Tiredness) and PAIN (pain comes and goes). At the time of the report, CHEST PAIN (sudden and quick pain in my chest), PAIN IN EXTREMITY (pain in her arm), ARTHRALGIA (Joint pain), FATIGUE (Tiredness) and PAIN (pain comes and goes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid-19) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid-19). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid-19) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Mass, Rash, Vaccination site erythema, Vaccination site swelling
Clinical narrative: She reports that the injection site became swollen; warm to the touch; little lump; it looks like its forming a hickey on my arm; A rash in circles; injection site red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch), MASS (little lump), CONTUSION (it looks like its forming a hickey on my arm), RASH (A rash in circles) and VACCINATION SITE ERYTHEMA (injection site red) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch), MASS (little lump), CONTUSION (it looks like its forming a hickey on my arm), RASH (A rash in circles) and VACCINATION SITE ERYTHEMA (injection site red). On an unknown date, the patient experienced VACCINATION SITE SWELLING (She reports that the injection site became swollen). At the time of the report, VACCINATION SITE WARMTH (warm to the touch), MASS (little lump), CONTUSION (it looks like its forming a hickey on my arm), RASH (A rash in circles), VACCINATION SITE ERYTHEMA (injection site red) and VACCINATION SITE SWELLING (She reports that the injection site became swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included warm or cold compress and Tylenol.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: She reports that the injection site became swollen; warm to the touch; little lump; it looks like its forming a hickey on my arm; A rash in circles; injection site red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch), MASS (little lump), CONTUSION (it looks like its forming a hickey on my arm), RASH (A rash in circles) and VACCINATION SITE ERYTHEMA (injection site red) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch), MASS (little lump), CONTUSION (it looks like its forming a hickey on my arm), RASH (A rash in circles) and VACCINATION SITE ERYTHEMA (injection site red). On an unknown date, the patient experienced VACCINATION SITE SWELLING (She reports that the injection site became swollen). At the time of the report, VACCINATION SITE WARMTH (warm to the touch), MASS (little lump), CONTUSION (it looks like its forming a hickey on my arm), RASH (A rash in circles), VACCINATION SITE ERYTHEMA (injection site red) and VACCINATION SITE SWELLING (She reports that the injection site became swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included warm or cold compress and Tylenol.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Eye irritation, Eye pruritus, Myalgia
Clinical narrative: Blurred vision; itchy eyes; Burning eyes; Rash on face; muscle soreness to the extent that he feels like he just ran a 20 mile race; weak; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), DIZZINESS (Dizzy), VISION BLURRED (Blurred vision), EYE PRURITUS (itchy eyes) and EYE IRRITATION (Burning eyes) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, the patient experienced ASTHENIA (weak), DIZZINESS (Dizzy), RASH (Rash on face) and MYALGIA (muscle soreness to the extent that he feels like he just ran a 20 mile race). On 03-May-2021, the patient experienced VISION BLURRED (Blurred vision), EYE PRURITUS (itchy eyes) and EYE IRRITATION (Burning eyes). At the time of the report, ASTHENIA (weak), DIZZINESS (Dizzy), VISION BLURRED (Blurred vision), EYE PRURITUS (itchy eyes), EYE IRRITATION (Burning eyes), RASH (Rash on face) and MYALGIA (muscle soreness to the extent that he feels like he just ran a 20 mile race) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Vision blurred
Clinical narrative: Blurred vision; itchy eyes; Burning eyes; Rash on face; muscle soreness to the extent that he feels like he just ran a 20 mile race; weak; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), DIZZINESS (Dizzy), VISION BLURRED (Blurred vision), EYE PRURITUS (itchy eyes) and EYE IRRITATION (Burning eyes) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, the patient experienced ASTHENIA (weak), DIZZINESS (Dizzy), RASH (Rash on face) and MYALGIA (muscle soreness to the extent that he feels like he just ran a 20 mile race). On 03-May-2021, the patient experienced VISION BLURRED (Blurred vision), EYE PRURITUS (itchy eyes) and EYE IRRITATION (Burning eyes). At the time of the report, ASTHENIA (weak), DIZZINESS (Dizzy), VISION BLURRED (Blurred vision), EYE PRURITUS (itchy eyes), EYE IRRITATION (Burning eyes), RASH (Rash on face) and MYALGIA (muscle soreness to the extent that he feels like he just ran a 20 mile race) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives go off and new ones appear; Hives are itchy; Hives are itchy; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives are itchy), PRURITUS (Hives are itchy) and URTICARIA (Hives go off and new ones appear) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced URTICARIA (Hives are itchy). 20-Apr-2021, the patient experienced PRURITUS (Hives are itchy). On an unknown date, the patient experienced URTICARIA (Hives go off and new ones appear). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives are itchy), PRURITUS (Hives are itchy) and URTICARIA (Hives go off and new ones appear) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication includes Heart medication,Blood clots medication. treatment information include Allergies pills.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Pain in extremity
Clinical narrative: vaccination from a facility five days after the expiration of the vial; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and EXPIRED PRODUCT ADMINISTERED (vaccination from a facility five days after the expiration of the vial) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL and LOVASTATIN for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccination from a facility five days after the expiration of the vial). At the time of the report, PAIN IN EXTREMITY (Sore arm) and EXPIRED PRODUCT ADMINISTERED (vaccination from a facility five days after the expiration of the vial) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old received vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-207241 (Patient Link).
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pain in extremity
Clinical narrative: Received both doses of Moderna Vaccine while pregnant; Arm soreness; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Received both doses of Moderna Vaccine while pregnant) and PAIN IN EXTREMITY (Arm soreness) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 18-Mar-2021 and the estimated date of delivery was 23-Dec-2021. On 09-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Received both doses of Moderna Vaccine while pregnant) and PAIN IN EXTREMITY (Arm soreness). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  third week of the pregnancy.  On 09-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Received both doses of Moderna Vaccine while pregnant) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm soreness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported. Treatment information was not provided.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: soreness; little tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness) and FATIGUE (little tired) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 025L20A) for COVID-19 vaccination.     The patient's past medical history included Autoimmune hemolytic anemia, Gaucher's disease type I, Kidney stones, Gallbladder removal, Shoulder replacement (Both shoulders replaced) and Joint arthrodesis. Concurrent medical conditions included Allergy to antibiotic.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (soreness) and FATIGUE (little tired). At the time of the report, PAIN (soreness) and FATIGUE (little tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. No Relevant concomitant medications was reported. Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-114596 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114596:1st dose
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itchy large rash down back; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy large rash down back) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced RASH PRURITIC (Itchy large rash down back). At the time of the report, RASH PRURITIC (Itchy large rash down back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.  No treatment information was provided.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass
Clinical narrative: Golf ball sized nodule underneath the left armpit; This spontaneous case was reported by a pharmacist and describes the occurrence of AXILLARY MASS (Golf ball sized nodule underneath the left armpit) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 07-May-2021, the patient experienced AXILLARY MASS (Golf ball sized nodule underneath the left armpit). At the time of the report, AXILLARY MASS (Golf ball sized nodule underneath the left armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provider by the reporter.  Treatment information was not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasal discomfort, Pain in extremity
Clinical narrative: Soreness; Slightly tired; A little pressure in the sinus area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness), FATIGUE (Slightly tired) and NASAL DISCOMFORT (A little pressure in the sinus area) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced PAIN IN EXTREMITY (Soreness), FATIGUE (Slightly tired) and NASAL DISCOMFORT (A little pressure in the sinus area). At the time of the report, PAIN IN EXTREMITY (Soreness), FATIGUE (Slightly tired) and NASAL DISCOMFORT (A little pressure in the sinus area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment The consumer is taking Aleve, and Advil PM to try to alleviate the symptoms.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site bruising, Vaccination site pain
Clinical narrative: bruising around vaccination site; soreness of the right arm which was injected; itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), VACCINATION SITE BRUISING (bruising around vaccination site) and VACCINATION SITE PAIN (soreness of the right arm which was injected) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included ENALAPRIL, CARVEDILOL, SOTALOL (SOTALOL AF [SOTALOL]) and FUROSEMIDE (LASIX [FUROSEMIDE]) for an unknown indication.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced PRURITUS (itching) and VACCINATION SITE PAIN (soreness of the right arm which was injected). On an unknown date, the patient experienced VACCINATION SITE BRUISING (bruising around vaccination site). At the time of the report, PRURITUS (itching) and VACCINATION SITE PAIN (soreness of the right arm which was injected) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment includes use an ice pack- exercised by running the vacuum and arm exercises of youtube by nurse.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Body aches,sore arm; headache; soreness at the vaccination site; Super tired; chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MYALGIA (Body aches,sore arm), FATIGUE (Super tired), CHILLS (chills) and HEADACHE (headache) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included Aspirin                                                        Blood clot disorder for an unknown indication.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced PYREXIA (Fever), FATIGUE (Super tired) and CHILLS (chills). On an unknown date, the patient experienced MYALGIA (Body aches,sore arm), HEADACHE (headache) and VACCINATION SITE PAIN (soreness at the vaccination site). At the time of the report, PYREXIA (Fever), MYALGIA (Body aches,sore arm), FATIGUE (Super tired), CHILLS (chills), HEADACHE (headache) and VACCINATION SITE PAIN (soreness at the vaccination site) outcome was unknown. Not Provided
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Body aches,sore arm; headache; soreness at the vaccination site; Super tired; chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MYALGIA (Body aches,sore arm), FATIGUE (Super tired), CHILLS (chills) and HEADACHE (headache) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included Aspirin                                                        Blood clot disorder for an unknown indication.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced PYREXIA (Fever), FATIGUE (Super tired) and CHILLS (chills). On an unknown date, the patient experienced MYALGIA (Body aches,sore arm), HEADACHE (headache) and VACCINATION SITE PAIN (soreness at the vaccination site). At the time of the report, PYREXIA (Fever), MYALGIA (Body aches,sore arm), FATIGUE (Super tired), CHILLS (chills), HEADACHE (headache) and VACCINATION SITE PAIN (soreness at the vaccination site) outcome was unknown. Not Provided
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain on injection arm, and has gotten worse over time; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain on injection arm, and has gotten worse over time) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain on injection arm, and has gotten worse over time). At the time of the report, VACCINATION SITE PAIN (Pain on injection arm, and has gotten worse over time) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication and treatment medications was not provided.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction, Feeling abnormal, Joint swelling, Pain in extremity
Clinical narrative: did have some side effects; left arm was sore initially; have a ball like something on my elbow/feels like it has fluid in it/it is soft; Felt like I'm having disease again for 48 hours; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (did have some side effects), PAIN IN EXTREMITY (left arm was sore initially), JOINT SWELLING (have a ball like something on my elbow/feels like it has fluid in it/it is soft) and FEELING ABNORMAL (Felt like I'm having disease again for 48 hours) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced ADVERSE REACTION (did have some side effects), PAIN IN EXTREMITY (left arm was sore initially), JOINT SWELLING (have a ball like something on my elbow/feels like it has fluid in it/it is soft) and FEELING ABNORMAL (Felt like I'm having disease again for 48 hours). At the time of the report, ADVERSE REACTION (did have some side effects), PAIN IN EXTREMITY (left arm was sore initially), JOINT SWELLING (have a ball like something on my elbow/feels like it has fluid in it/it is soft) and FEELING ABNORMAL (Felt like I'm having disease again for 48 hours) outcome was unknown. Not Provided          Treatment information included Advil and Ice.  Action taken with response to the events were not applicable.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Mobility decreased, Myalgia, Nausea
Clinical narrative: Limited mobility; Diarrhea; Fatigue; Severe muscle aches, especially in thighs; Nausea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Severe muscle aches, especially in thighs), NAUSEA (Nausea) and DIARRHOEA (Diarrhea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included GABAPENTIN, LISINOPRIL, OMEPRAZOLE, DICLOFENAC, TIZANIDINE and VENLAFAXINE for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Severe muscle aches, especially in thighs), NAUSEA (Nausea) and MOBILITY DECREASED (Limited mobility). 29-Apr-2021, the patient experienced DIARRHOEA (Diarrhea). On 03-May-2021, PYREXIA (Fever), FATIGUE (Fatigue), NAUSEA (Nausea) and DIARRHOEA (Diarrhea) had resolved. At the time of the report, MYALGIA (Severe muscle aches, especially in thighs) and MOBILITY DECREASED (Limited mobility) outcome was unknown.            Concomitant product used included Gabapentin, Lisinopril, Omeprazole, diclofenac, tizanidine, Venlafaxine.  Treatment medication included OTC potassium, Gatorade, pickle juice, mustard, and water.  Additionally, patient noted that she only experienced nausea following her first vaccine dose.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Limited mobility; Diarrhea; Fatigue; Severe muscle aches, especially in thighs; Nausea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Severe muscle aches, especially in thighs), NAUSEA (Nausea) and DIARRHOEA (Diarrhea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included GABAPENTIN, LISINOPRIL, OMEPRAZOLE, DICLOFENAC, TIZANIDINE and VENLAFAXINE for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced PYREXIA (Fever), FATIGUE (Fatigue), MYALGIA (Severe muscle aches, especially in thighs), NAUSEA (Nausea) and MOBILITY DECREASED (Limited mobility). 29-Apr-2021, the patient experienced DIARRHOEA (Diarrhea). On 03-May-2021, PYREXIA (Fever), FATIGUE (Fatigue), NAUSEA (Nausea) and DIARRHOEA (Diarrhea) had resolved. At the time of the report, MYALGIA (Severe muscle aches, especially in thighs) and MOBILITY DECREASED (Limited mobility) outcome was unknown.            Concomitant product used included Gabapentin, Lisinopril, Omeprazole, diclofenac, tizanidine, Venlafaxine.  Treatment medication included OTC potassium, Gatorade, pickle juice, mustard, and water.  Additionally, patient noted that she only experienced nausea following her first vaccine dose.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored in the refrigerator for 31 days was administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine stored in the refrigerator for 31 days was administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine stored in the refrigerator for 31 days was administered). On 07-May-2021, PRODUCT STORAGE ERROR (Vaccine stored in the refrigerator for 31 days was administered) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medicines was not reported by reporter  treatment information was not provided
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joint pain the first day after vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain the first day after vaccine) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 031BZ1A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced ARTHRALGIA (Joint pain the first day after vaccine). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. On 30-Apr-2021, ARTHRALGIA (Joint pain the first day after vaccine) had resolved. Not Provided
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous, Skin burning sensation, Skin exfoliation
Clinical narrative: Red rash; It's like a bad sunburn, it's burning; It's itching; It's peeling; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash), SKIN BURNING SENSATION (It's like a bad sunburn, it's burning), PRURITUS (It's itching) and SKIN EXFOLIATION (It's peeling) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 025A21A) for COVID-19 vaccination.     The patient's past medical history included Shoulder replacement. Concurrent medical conditions included Celiac disease.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), SKIN BURNING SENSATION (It's like a bad sunburn, it's burning), PRURITUS (It's itching) and SKIN EXFOLIATION (It's peeling). The patient was treated with CLOBETASOL PROPIONATE at a dose of UNK dosage form and DOXYCYCLINE at a dose of UNK dosage form. At the time of the report, RASH ERYTHEMATOUS (Red rash), SKIN BURNING SENSATION (It's like a bad sunburn, it's burning), PRURITUS (It's itching) and SKIN EXFOLIATION (It's peeling) outcome was unknown. Not Provided          No Concomitant medication details was provided.    This case was linked to MOD-2021-114607 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow-up received on 26-Jun-2021:No New Information was added